Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GEMCITABINE vs GEMFIBROZIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GEMCITABINE vs GEMFIBROZIL: Safety Overview

Metric GEMCITABINE GEMFIBROZIL
Total FAERS Reports 31,328 1,089
Deaths Reported 5,142 101
Death Rate 16.4% 9.3%
Hospitalizations 12,268 286
Average Patient Age 61.2 yrs 56.7 yrs
% Female Patients 48.4% 49.9%
FDA Approval Date Apr 11, 2016 Approved Prior to Jan 1, 1982
Manufacturer Hikma Pharmaceuticals USA Inc. Northwind Health Company, LLC
Route INTRAVENOUS ORAL
Marketing Status Discontinued Discontinued